Viewing Compound With Targets


Compound Report Overview

Compound Name: TEDISAMIL
Compound Identifier: 702293
Mol Structure 2D: 702293
Molecular Weight: 288
Formula: C19 H32 N2
Development Status: Clinical, Phase II/III
SMILES: C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C53CCCC5
Compound Targets
Compound Gene Gene Type View
TEDISAMIL 143611 ATP-sensitive inwardly rectifying K+ channel, BIR(Kir6.2) View
TEDISAMIL 168070 potassium inwardly-rectifying channel, subfamily J, member 15 View
TEDISAMIL 132780 potassium inwardly-rectifying channel, subfamily J, member 8 View
TEDISAMIL 168010 hypothetical gene supported by NM_053804 View
TEDISAMIL 129349 inward rectifier potassium channel Kir7.1 View
TEDISAMIL 129358 potassium inwardly-rectifying channel, subfamily J, member 14 View
TEDISAMIL 127550 potassium inwardly-rectifying channel, subfamily J, member 5 View
TEDISAMIL 144037 potassium inwardly-rectifying channel, subfamily J, member 10 View
TEDISAMIL 147429 R.rattus mRNA for inward rectifier 9 View
TEDISAMIL 153850 potassium inwardly-rectifying channel, subfamily J, member 3 View
TEDISAMIL 152007 potassium inwardly-rectifying channel, subfamily J, member 2 View
TEDISAMIL 144038 potassium inwardly-rectifying channel, subfamily J, member 4 View
TEDISAMIL 148987 potassium inwardly-rectifying channel, subfamily J, member 1 View
TEDISAMIL 144045 potassium inwardly-rectifying channel subfamily J9 (Rn.) (DBSS_strong) View
TEDISAMIL 127630 potassium inwardly-rectifying channel, subfamily J, member 6 View
TEDISAMIL 127781 potassium inwardly-rectifying channel, subfamily J, member 12 View